VPC-18005
VPC-18005 is a luciferase inhibitor that directly targets the ERG-ETS domain, blocking ERG's DNA binding and subsequent transcriptional activity. This small molecule is a valuable research tool for studying ERG-driven oncogenesis in prostate cancer and leukemia, applicable in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2242480-48-2
Product Name Alternative
Cancer, inhibit, luciferase, Inhibitor, ETS, ERG, prostate, PNT1B, VPC 18005, VPC18005, VPC-18005
Field of Research
Cell Biology, Molecular Biology
Purity
99.79% (May vary between batches)
Solubility
DMSO:60 mg/mL (187.86 mM)
Smiles
N (/N=C\C1=CC=C (C (C) C) C=C1) =C\2/SC (CC (O) =O) C (=O) N2
Molecular Formula
C15H17N3O3S
Molecular Weight
319.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1384662-01 0.02 mg (E-Coli)
Recombinant Paramecium tetraurelia Caltractin ICL1b (Icl1b)
Sign In for Pricing
View Details MBS1384662-02 0.1 mg (E-Coli)
Recombinant Paramecium tetraurelia Caltractin ICL1b (Icl1b)
Sign In for Pricing
View Details MBS1384662-03 0.02 mg (Yeast)
Recombinant Paramecium tetraurelia Caltractin ICL1b (Icl1b)
Sign In for Pricing
View Details MBS1384662-04 0.1 mg (Yeast)
Recombinant Paramecium tetraurelia Caltractin ICL1b (Icl1b)
Sign In for Pricing
View Details MBS1384662-05 0.02 mg (Baculovirus)
Recombinant Paramecium tetraurelia Caltractin ICL1b (Icl1b)
Sign In for Pricing
View Details MBS1384662-06 0.02 mg (Mammalian-Cell)
Recombinant Paramecium tetraurelia Caltractin ICL1b (Icl1b)
Sign In for Pricing
View Details